APA

Atzpodien J., Schmitt E., Gertenbach U., Fornara P., Heynemann H., Maskow A., Ecke M., Wöltjen H. H., Jentsch H., Wieland W., Wandert T. & Reitz M. (20050421). Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). : British journal of cancer.

Chicago

Atzpodien J, Schmitt E, Gertenbach U, Fornara P, Heynemann H, Maskow A, Ecke M, Wöltjen H H, Jentsch H, Wieland W, Wandert T and Reitz M. 20050421. Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). : British journal of cancer.

Harvard

Atzpodien J., Schmitt E., Gertenbach U., Fornara P., Heynemann H., Maskow A., Ecke M., Wöltjen H. H., Jentsch H., Wieland W., Wandert T. and Reitz M. (20050421). Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). : British journal of cancer.

MLA

Atzpodien J, Schmitt E, Gertenbach U, Fornara P, Heynemann H, Maskow A, Ecke M, Wöltjen H H, Jentsch H, Wieland W, Wandert T and Reitz M. Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). : British journal of cancer. 20050421.